MAPK3 and malignant colon neoplasm: In contrast to the ERK1/2 phosphorylation response to CCR7/CCL19 activation observed in immune cells [114], the colon cancer cells did not appear to express functional CCR7, since the cells failed to activate signaling pathways via CCL19 or CCL21 to ERK1/2 [113].